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SUMMARY 
Pancreatic islet B cells from Sprague-Dawley and Fisher 344 rats aged 3 27 months 
were separated from A and D cells by centrifugation over a linear percoll density gradient. 
and incubated in vitro with various concentrations of  glucose and somatostatin. Elevation 
of  glucose concentration in the incubation medium from 2.6 to 16.7 mM provokes an 
insulin secretory response that is independent of rat donor age. Inhibition of  the insulin 
secretory response by somatostatin is independent of  rat donor age beyond 12 months. 
These data indicate that the impaired regulation of  insulin secretion during aging observed 
previously in vivo and in vitro in intact islets may not be intrinsic to the B cells, but 
instead reflect changes in islet paracrine regulatory mechanisms that relate to the quality 
and/or quanti ty of  endogenous somatostatin and/or glucagon. 
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INTRODUCTION 
Impairments in glucose-stimulated insulin response that are detected in portal vein 
blood o f  aging rats [1] also are expressed in vitro when pancreatic islets of  Langerhans 
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are isolated from rat donors of increasing age [2-4] .  Subsequent mechanistic pursuits 
focussed primarily on molecular events which occur in B cells of intact islets, such as 
insulin biosynthesis and processing, glucose metabolism, and adenylate cyclase activity 
[2,5-9].  However, treatment of isolated islets from aged rats with somatostatin anti- 
bodies restores a substantial portion of the glucose-stimulated insulin response [10]. 
Furthermore, somatostatin secretion by isolated islets increases with rat donor age 
[10]. This suggests that certain age-associated events in B cells of intact islets may be 
secondary to changes in the regulation of glucose-stimulated secretion of insulin by endo- 
genous somatostatin, as well as by other paracrine factors. The present study was under- 
taken to assess the capability of purified islet B cells from rats of different ages for 
glucose-stimulated secretion of insulin in the presence and absence of added somato- 
statin. 
MATERIALS AND METHODS 
Isolation o f  pancreatic islets and B cells 
Male Sprague-Dawley and Fisher 344 rats were obtained from the Charles River 
Breeding Laboratories in Wilmington, MA at 2-4 ,  9 -12 ,  and 24-27 months of age. 
Conditions of maintenance at commercial and university animal facilities, as well as 
relevant pathology and mortality data, were described previously [11,12]. Removal of 
pancreas immediately following decapitation and isolation of pancreatic islets of Langer- 
hans by collagenase digestion were accomplished by modifications [13] of the methods 
of Lacy and Kostianovsky [ 14]. 
A mixed cell suspension containing A, B, and D cells was isolated from intact islets 
by modification of the method of Pipeleers and Pipeleers-Mirichal [15]. B cells were 
separated from A and D cells as follows. The mixed islet cell suspension was loaded at 
a concentration of 1.0-1.5 × 10 3 cells/ml onto a linear gradient of percoll and centri- 
fuged for 5 rain at 2000 g. Various density fractions were separated according to the 
distribution of density marker beads. Cells were concentrated by centrifugation at 150 g 
for 10 min. Recovery of cells was determined by hemocytometric analyses of  numbers 
of cells in the loaded mixed islet cell suspension and in each density fraction immediately 
prior and subsequent to density gradient centrifugation. Viability was determined as the 
percentage of cells that do not stain with Trypan Blue dye in any sample. 
Identification of A, B, and D cells was determined immunohistochemically, as well 
as by chemical extraction of glucagon, insulin and somatostatin. Formalin-fixed cells 
taken from the first density fraction of the percoll-gradient were stained by immuno- 
peroxidase using the avidin-biotin complex method (ABC) with an unlabeled primary 
antibody, biotinylated secondary antibody, and a preformed avidin-biotin-horseradish 
peroxidase complex (Vector Labs., Burlingame, CA). Cells were treated with diamino- 
benzidine and counterstained with hematoxylin [16]. Following density gradient centri- 
fugation, each separated density fraction was extracted for 20 h in absolute ethanol/ 
water/concentrated HC1 in volume proportions of 150:47:3, and assessed for content 
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of glucagon, insulin, and somatostatin. The concentration of insulin was determined 
by specific solid phase radioimmunoassay [2]. Rat insulin standards were obtained 
from NOVO (Copenhagen), and [12Sl]insulin from New England Nuclear. The inter- 
assay variation was 6% and intra-assay variation, 3%. 
Radioimmunoassay of somatostatin was performed according to the procedure de- 
scribed by Gerich et al. [17]. Synthetic somatostatin standards were purchased from 
Beckman and [12Sl] somatostatin from New England Nuclear. The antisera was a generous 
gift from Dr. J. Gerich, the Mayo Clinic. This antibody responds with 50% binding at 
1 : 12 000 to 1:50 000 final dilution. Separation of bound and free somatostatin was 
accomplished by addition of 500/~1 dextran-coated charcoal. The intra-assay variability 
was about 10% and the interassay variability was about 16%. 
The radioimmunoassay for glucagon was performed by the University of Michigan 
Diabetes Research and Training Center. Beef-pork glucagon was used as 12Sl-labelled 
trace (New England Nuclear) and standard. Separation of the bound and free fractions 
was accomplished by precipitation with a second antibody (Ann Arbor). The interassay 
variability was 10.2% and intraassay variability was 7.5% [ 18]. 
Insulin secretion studies 
Percoll density gradient fraction 1 contained the greatest amount of B cells, and 
was utilized for all studies of insulin secretion. Cell suspensions containing 4000 B cells 
in 0.1 ml were preincubated for 30 min with 1.0 ml Krebs buffer containing 2.67 mM 
glucose at 37°C and 95/5% O2/CO2, Cells were pelleted by centrifugation at 150 g at 
4°C for 10 min. Cell-free aliquots of the solution were assayed for zero-time content 
of insulin. The pelleted ceils were washed twice with the same solution, and then were 
suspended in solutions containing varying amounts of glucose and somatostatin. Follow- 
ing a l-h incubation under conditions identical to those of the preincubation, cells were 
pelleted by centrifugation, and the cell-free solution was assayed for insulin content, 
as was the cell pellet following extraction with acid ethanol. 
Statistical analysis 
The different treatment groups and age groups were compared by the BMDP mixed 
effects three-way analysis of variance (BMDP3V). P values were adjusted using the Bon- 
ferronni Multiple Comparisions Procedure [19]. 
EXPERIMENTAL RESULTS 
The distribution of extractable insulin, glucagon, and somatostatin among seven 
percoll density gradient fractions is illustrated in Fig. 1 for 2-3-month-old Spragu~- 
Dawley rats. Fraction 1 contains slightly more than 60% of the total insulin and less 
than 10% of the total glucagon and somatostatin recovered from the entire gradient. 
Insulin content in fraction 2 decreases to less than 25% of total recovered insulin, and 
the remaining 10-15% of the extractable insulin is distributed among fractions 3-7 .  
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t:ig. 1. Extractable hormone distribution in density gradient fractions. Mixed islet cell suspensions 
were prepared from pancreases of 2-month-old Sprague-Dawley rats, and separated by PercoU density 
gradient centrifugation into seven fractions. The cells from each density gradient fraction were extract- 
ed in acid-ethanol and assayed for content of insulin, glucagon, and somatostatin. Data are expressed 
as the mean percentage +_ S.E.M. of each respective total hormone extracted from the entire Percoll 
gradient for seven different cell preparations. ~, insulin; X, glucagon; n, somatostatin. 
Extractable glucagon is found primarily in fraction 2, and extractable somatostatin 
apparently is distributed approximately equally among the seven gradient fractions. 
lmmunohistochemical analysis of the cells in fraction 1 revealed the following distri- 
bution: B (85%); A (13%), and D (2%). This cell distribution did not change between 
2 and 27 months of  age. Although data are not presented, the patterns of density gradient 
fractionation are identical at 2, 12, 18 and 27 months of age in Sprague-Dawley and 
Fisher rats. 
The effect of  glucose and somatostatin on secretion of  insulin by partially purified 
islet B cells from rat donors of  different ages is indicated in Table I. The amount of  
insulin secretion per cell preparation during a 1-h period varies as much as lO-fold from 
one preparation to another in response to 2.6 mM glucose. However, when effects of 
higher glucose concentration and somatostatin on each cell preparation are normalized 
with respect to its insulin secretion in response to 2.6 mM glucose, significant trends are 
apparent. Elevation of the glucose concentration in the incubation medium to 16.7 mM 
increases the amount of  insulin secretion by approximately 40% by B cells from donor 
rats aged 2 - 2 7  months. Somatostatin inhibits the insulin response to 16.7 mM glucose 
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TABLE I 
INHIBITION OF GLUCOSE-STIMULATED SECRETION OF INSULIN BY SOMATOSTATIN 
Somatostatin Age Insulin secretion 
concentration (months} (percent response} 
(ng/mt) 
0 2-3 145 +- 7.2 (a) 
0 12-27 134 +7.5 (b) 
1 2-3 131 + 9 . 0  (c) 
1 12-27 116 _+4.0 (d) 
5 2-3 102 +4.0 (e) 
5 12--27 112 -+4.0 (f) 
10 2 3 91 -+ 7.5 (g) 
10 12-27 94 +7.0 (h) 
Insulin secretion is expressed as the normalized 60-min response to 16.7 mM glucose relative to that 
of 2.6 mM glucose by the identical cell preparation. Mean values + S.I(.M. were calculated for six 
separate ceil preparations at ages 2 3, 12-15, 18 21, and 24-27 months. Values for the three 
oldest groups were combined because they were identical. P values refer to the lower case letters 
following each insulin response: 
bvs. d,P < 0.01. 
bvs. f ,P<O.OI.  
bvs. h.P < 0.01. 
a vs. c, not significant. 
a vs. e.P < 0.001. 
a vs. g, P < 0.001. 
similarly by B cells from donor rats of different ages, although there is a small, statistic- 
ally significant increase in sensitivity to the lowest utilized concentration of somatostatin 
by cells from older rats. For all of the data presented in Table 1, values were identical 
using cells from Sprague-Dawley and Fisher 344 rat donors at 12, 18, and 27 months 
of age. Therefore, these values were combined and expressed as mean -+ S.E.M. for old 
rats. 
DISCUSSION AND CONCLUSIONS 
Partial purif ication o r B  cells 
Percoll density gradient centrifugation provides a convenient, rapid and reproducible 
method for separation of B cells with respect to A and D cells. The density of B cells 
(1.065 g/ml) is less than that of A (1.068 g/ml) and D (1.070og/ml) cells. Therefore, 
B cells remain at the top of the gradient. 
Separation of B cells on the gradient requires approximately 5 min, as compared 
with 35 min on the elutriator [15]. Percentage recovery (75%) and viability (90%) are 
similar utilizing either method. Under the light microscope the B cells appear undamaged 
and primarily in single particle form. 
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Insulin secretion 
When the concentration of glucose in the incubation medium is elevated from 2.7 
to 16.7 mM, partially purified B cells from rats aged 2-27  months increase insulin 
secretion by approximately 40%. This magnitude of insulin response is considerably 
smaller than that observed previously for intact islets by this laboratory [2,10], as well 
as by others [3]. However, such responsiveness is in agreement with results of others 
who examined dispersed islet cells [20-24].  These data lend additional support to 
the concept that paracrine interrelationships which characterize intact islets are important 
to glucose-stimulated secretion of insulin. 
Inhibition of insulin secretion by somatostatin provides credibility for the physio- 
logical integrity of the partially purified B cell preparation that is described in the present 
article. Apparently, the inability of earlier studies to demonstrate the inhibitory effect 
of somatostatin on isolated B cells [25-27] is overcome when islet digestion is performed 
with trypsin-flee collagenase. 
Impact o f  aging 
Isolated B cells from donor rats aged 3 27 months show no difference in magnitude 
of insulin secretory response to a glucose challenge. Futhermore, somatostatin inhibits 
insulin secretion similarly by isolated B cells from rats of different ages. The small in- 
crease in sensitivity to inhibition at the lowest utilized concentration of somatostatin 
is expressed between 2 and 12 months of age, and probably does not relate causally to 
differences that were observed previously at much later points in the lifespan. Therefore, 
differences in glucose-stimulated secretion of insulin during aging probably are secondary 
to alterations in islet paracrine control mechanisms which address the quality and/or 
quantity of endogenous glucagon and/or somatostatin that is available to B cells within 
intact islets. 
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